The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era
Abstract
Background— Novel therapies have recently become available for pulmonary arterial hypertension. We conducted a study to characterize mortality in a multicenter prospective cohort of patients diagnosed with idiopathic, familial, or anorexigen-associated pulmonary arterial hypertension in the modern management era. Methods and Results— Between October 2002 and October 2003, 354 consecutive adult patients with idiopathic, familial, or anorexigen-associated pulmonary arterial hypertension (56 incident and 298 prevalent cases) were prospectively enrolled. Patients were followed up for 3 years, and survival rates were analyzed. For incident cases, estimated survival (95% confidence intervals [CIs]) at 1, 2, and 3 years was 85.7% (95% CI, 76.5 to 94.9), 69.6% (95% CI, 57.6 to 81.6), and 54.9% (95% CI, 41.8 to 68.0), respectively. In a combined analysis population (incident patients and prevalent patients diagnosed within 3 years before study entry; n=190), 1-, 2-, and 3-year survival estimates were 82.9% (95% CI, 72.4 to 95.0), 67.1% (95% CI, 57.1 to 78.8), and 58.2% (95% CI, 49.0 to 69.3), respectively. Individual survival analysis identified the following as significantly and positively associated with survival: female gender, New York Heart Association functional class I/II, greater 6-minute walk distance, lower right atrial pressure, and higher cardiac output. Multivariable analysis showed that being female, having a greater 6-minute walk distance, and exhibiting higher cardiac output were jointly significantly associated with improved survival. Conclusions— In the modern management era, idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension remains a progressive, fatal disease. Mortality is most closely associated with male gender, right ventricular hemodynamic function, and exercise limitation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationAuthors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
Self-citationD'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Bosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Self-citationPrimary Pulmonary Hypertension: A National Prospective Study
RICH, S., DANTZKER, D. R., AYRES, S. M., BERGOFSKY, E. H., BRUNDAGE, B. H., DETRE, K. M., FISHMAN, A. P., GOLDRING, R. M., GROVES, B. M., KOERNER, S. K., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-216 · Cited by 2,039
Pulmonary Arterial Hypertension in France: Results from a National Registry
Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaici, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1668oc · Cited by 2,000
Self-citationTreatment of Pulmonary Arterial Hypertension
Humbert, M., Sitbon, O., & Simonneau, G. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040291 · Cited by 1,707
Self-citationCellular and molecular pathobiology of pulmonary arterial hypertension
Humbert, M., Morrell, N. W., Archer, S. L., Stenmark, K. R., MacLean, M. R., Lang, I. M., Christman, B. W., Weir, E. K., Eickelberg, O., Voelkel, N. F., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.029 · Cited by 1,576
Self-citationPulmonary Arterial Hypertension
Farber, H. W., & Loscalzo, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035488 · Cited by 1,463
Cited by
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citation2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac237 · Cited by 3,975
Self-citation2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00879-2022 · Cited by 2,247
Self-citationInitial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
Galiè, N., Barberà, J. A., Frost, A. E., Ghofrani, H.-A., Hoeper, M. M., McLaughlin, V. V., Peacock, A. J., Simonneau, G., Vachiery, J.-L., Grünig, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413687 · Cited by 1,182
Self-citationBenza, R. L., Miller, D. P., Barst, R. J., Badesch, D. B., Frost, A. E., & McGoon, M. D. (2012) · Chest · doi:10.1378/chest.11-1460 · Cited by 1,104
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Sitbon, O., Channick, R., Chin, K. M., Frey, A., Gaine, S., Galiè, N., Ghofrani, H.-A., Hoeper, M. M., Lang, I. M., Preiss, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503184 · Cited by 1,060
Self-citationA global view of pulmonary hypertension
Hoeper, M. M., Humbert, M., Souza, R., Idrees, M., Kawut, S. M., Sliwa-Hahnle, K., Jing, Z.-C., & Gibbs, J. S. R. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00543-3 · Cited by 1,039
Self-citationPulmonary arterial hypertension: pathogenesis and clinical management
Thenappan, T., Ormiston, M. L., Ryan, J. J., & Archer, S. L. (2018) · BMJ · doi:10.1136/bmj.j5492 · Cited by 998
Right Heart Adaptation to Pulmonary Arterial Hypertension
Vonk-Noordegraaf, A., Haddad, F., Chin, K. M., Forfia, P. R., Kawut, S. M., Lumens, J., Naeije, R., Newman, J., Oudiz, R. J., Provencher, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.027 · Cited by 982
Risk stratification and medical therapy of pulmonary arterial hypertension
Galiè, N., Channick, R. N., Frantz, R. P., Grünig, E., Jing, Z. C., Moiseeva, O., Preston, I. R., Pulido, T., Safdar, Z., Tamura, Y., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01889-2018 · Cited by 819
van de Veerdonk, M. C., Kind, T., Marcus, J. T., Mauritz, G.-J., Heymans, M. W., Bogaard, H.-J., Boonstra, A., Marques, K. M. J., Westerhof, N., & Vonk-Noordegraaf, A. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.068 · Cited by 846
Pulmonary Arterial Hypertension
Hassoun, P. M. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2000348 · Cited by 693
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
Humbert, M., Sitbon, O., Yaïci, A., Montani, D., O'Callaghan, D. S., Jaïs, X., Parent, F., Savale, L., Natali, D., Günther, S., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00057010 · Cited by 674
Self-citationDelcroix, M., Lang, I., Pepke-Zaba, J., Jansa, P., D’Armini, A. M., Snijder, R., Bresser, P., Torbicki, A., Mellemkjaer, S., Lewczuk, J., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.016522 · Cited by 670
Self-citationPulmonary Arterial Hypertension in Patients Treated by Dasatinib
Montani, D., Bergot, E., Günther, S., Savale, L., Bergeron, A., Bourdin, A., Bouvaist, H., Canuet, M., Pison, C., Macro, M., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.079921 · Cited by 659
Self-citationHoeper, M. M., Barst, R. J., Bourge, R. C., Feldman, J., Frost, A. E., Galié, N., Gómez-Sánchez, M. A., Grimminger, F., Grünig, E., Hassoun, P. M., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000765 · Cited by 574
Self-citationLing, Y., Johnson, M. K., Kiely, D. G., Condliffe, R., Elliot, C. A., Gibbs, J. S. R., Howard, L. S., Pepke-Zaba, J., Sheares, K. K. K., Corris, P. A., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0383oc · Cited by 560
Benza, R. L., Gomberg-Maitland, M., Miller, D. P., Frost, A., Frantz, R. P., Foreman, A. J., Badesch, D. B., & McGoon, M. D. (2012) · Chest · doi:10.1378/chest.11-0676 · Cited by 557
Pulmonary Arterial Hypertension
McGoon, M. D., Benza, R. L., Escribano-Subias, P., Jiang, X., Miller, D. P., Peacock, A. J., Pepke-Zaba, J., Pulido, T., Rich, S., Rosenkranz, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.023 · Cited by 524
Self-citationEpidemiology and treatment of pulmonary arterial hypertension
Lau, E. M. T., Giannoulatou, E., Celermajer, D. S., & Humbert, M. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.84 · Cited by 507
Self-citationHoeper, M. M., Huscher, D., Ghofrani, H. A., Delcroix, M., Distler, O., Schweiger, C., Grunig, E., Staehler, G., Rosenkranz, S., Halank, M., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.026 · Cited by 466
ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre
Hurdman, J., Condliffe, R., Elliot, C. A., Davies, C., Hill, C., Wild, J. M., Capener, D., Sephton, P., Hamilton, N., Armstrong, I. J., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00078411 · Cited by 459
Survival in pulmonary hypertension in Spain: insights from the Spanish registry
Escribano-Subias, P., Blanco, I., López-Meseguer, M., Lopez-Guarch, C. J., Roman, A., Morales, P., Castillo-Palma, M. J., Segovia, J., Gómez-Sanchez, M. A., & Barberà, J. A. (2012) · European Respiratory Journal · doi:10.1183/09031936.00101211 · Cited by 415
Inflammation in Pulmonary Arterial Hypertension
Price, L. C., Wort, S. J., Perros, F., Dorfmüller, P., Huertas, A., Montani, D., Cohen-Kaminsky, S., & Humbert, M. (2012) · Chest · doi:10.1378/chest.11-0793 · Cited by 403
Self-citationUpfront triple combination therapy in pulmonary arterial hypertension: a pilot study
Sitbon, O., Jaïs, X., Savale, L., Cottin, V., Bergot, E., Macari, E. A., Bouvaist, H., Dauphin, C., Picard, F., Bulifon, S., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00116313 · Cited by 382
Self-citationHumbert, M., Yaici, A., de Groote, P., Montani, D., Sitbon, O., Launay, D., Gressin, V., Guillevin, L., Clerson, P., Simonneau, G., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30541 · Cited by 379
Self-citationAustin, E. D., Ma, L., LeDuc, C., Berman Rosenzweig, E., Borczuk, A., Phillips, J. A., Palomero, T., Sumazin, P., Kim, H. R., Talati, M. H., et al. (2012) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.111.961888 · Cited by 378
Olsson, K. M., Delcroix, M., Ghofrani, H. A., Tiede, H., Huscher, D., Speich, R., Grünig, E., Staehler, G., Rosenkranz, S., Halank, M., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.004526 · Cited by 372
Mocumbi, A., Humbert, M., Saxena, A., Jing, Z.-C., Sliwa, K., Thienemann, F., Archer, S. L., & Stewart, S. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00486-7 · Cited by 370
Self-citationManagement of Pulmonary Arterial Hypertension
McLaughlin, V. V., Shah, S. J., Souza, R., & Humbert, M. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.540 · Cited by 366
Self-citationRight Ventricular Diastolic Impairment in Patients With Pulmonary Arterial Hypertension
Rain, S., Handoko, M. L., Trip, P., Gan, C. T.-J., Westerhof, N., Stienen, G. J., Paulus, W. J., Ottenheijm, C. A. C., Marcus, J. T., Dorfmüller, P., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001873 · Cited by 363
Self-citationLong-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension
Montani, D., Savale, L., Natali, D., Jais, X., Herve, P., Garcia, G., Humbert, M., Simonneau, G., & Sitbon, O. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq170 · Cited by 362
Self-citationNickel, N., Golpon, H., Greer, M., Knudsen, L., Olsson, K., Westerkamp, V., Welte, T., & Hoeper, M. M. (2012) · European Respiratory Journal · doi:10.1183/09031936.00092311 · Cited by 361
Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension
de Man, F. S., Tu, L., Handoko, M. L., Rain, S., Ruiter, G., François, C., Schalij, I., Dorfmüller, P., Simonneau, G., Fadel, E., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0411oc · Cited by 346
Self-citationLahm, T., Douglas, I. S., Archer, S. L., Bogaard, H. J., Chesler, N. C., Haddad, F., Hemnes, A. R., Kawut, S. M., Kline, J. A., Kolb, T. M., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1160st · Cited by 343
Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension
Humbert, M., Lau, E. M. T., Montani, D., Jaïs, X., Sitbon, O., & Simonneau, G. (2014) · Circulation · doi:10.1161/circulationaha.114.006974 · Cited by 342
Self-citationStatement on Pregnancy in Pulmonary Hypertension from the Pulmonary Vascular Research Institute
Hemnes, A. R., Kiely, D. G., Cockrill, B. A., Safdar, Z., Wilson, V. J., Hazmi, M. A., Preston, I. R., MacLean, M. R., & Lahm, T. (2015) · Pulmonary Circulation · doi:10.1086/682230 · Cited by 334
Manes, A., Palazzini, M., Leci, E., Bacchi Reggiani, M. L., Branzi, A., & Galie, N. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht072 · Cited by 320
Hoeper, M. M., & Granton, J. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0662ci · Cited by 316
Pulmonary arterial hypertension
Montani, D., Günther, S., Dorfmüller, P., Perros, F., Girerd, B., Garcia, G., Jaïs, X., Savale, L., Artaud-Macari, E., Price, L. C., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-97 · Cited by 314
Self-citationThe Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups
Gall, H., Felix, J. F., Schneck, F. K., Milger, K., Sommer, N., Voswinckel, R., Franco, O. H., Hofman, A., Schermuly, R. T., Weissmann, N., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.02.016 · Cited by 313
Treatment Goals of Pulmonary Hypertension
McLaughlin, V. V., Gaine, S. P., Howard, L. S., Leuchte, H. H., Mathier, M. A., Mehta, S., Palazzini, M., Park, M. H., Tapson, V. F., & Sitbon, O. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.034 · Cited by 294
Self-citationPathobiology of pulmonary arterial hypertension and right ventricular failure
Voelkel, N. F., Gomez-Arroyo, J., Abbate, A., Bogaard, H. J., & Nicolls, M. R. (2012) · European Respiratory Journal · doi:10.1183/09031936.00046612 · Cited by 274
Lefèvre, G., Dauchet, L., Hachulla, E., Montani, D., Sobanski, V., Lambert, M., Hatron, P., Humbert, M., & Launay, D. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38029 · Cited by 274
Self-citationREVEAL: a contemporary US pulmonary arterial hypertension registry
McGoon, M. D., & Miller, D. P. (2012) · European Respiratory Review · doi:10.1183/09059180.00008211 · Cited by 271
The role of the right ventricle in pulmonary arterial hypertension
Vonk Noordegraaf, A., & Galiè, N. (2011) · European Respiratory Review · doi:10.1183/09059180.00006511 · Cited by 258
Gabler, N. B., French, B., Strom, B. L., Palevsky, H. I., Taichman, D. B., Kawut, S. M., & Halpern, S. D. (2012) · Circulation · doi:10.1161/circulationaha.112.105890 · Cited by 255
Ricard, N., Tu, L., Le Hiress, M., Huertas, A., Phan, C., Thuillet, R., Sattler, C., Fadel, E., Seferian, A., Montani, D., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007469 · Cited by 208
“8 years).(1) It is well known that pulmonary arteries display complex structural and functional changes in PAH and that pulmonary endothelial cell (EC) dysfunction plays a crucial role in the disease progression.”
BackgroundSelf-citationThe nox4 inhibitor gkt137831 attenuates hypoxia-induced pulmonary vascular cell proliferation
Green, D. E., Murphy, T. C., Kang, B.-Y., Kleinhenz, J. M., Szyndralewiez, C., Page, P., Sutliff, R. L., & Hart, C. M. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0418oc · Cited by 146
Schaffer, J. M., Singh, S. K., Joyce, D. L., Reitz, B. A., Robbins, R. C., Zamanian, R. T., & Mallidi, H. R. (2013) · Circulation · doi:10.1161/circulationaha.112.001080 · Cited by 69
“Others have shown that right atrial pressure (a measure of right-sided heart dysfunction; not available in the UNOS data set) predicts worse outcomes in IPAH, which may account in part for the poor wait-list outcomes among HLT-listed patients.(19,38,39) Although our survival analysis revealed improved outcomes for LUT…”
ResultAbnormal right ventricular relaxation in pulmonary hypertension.
Murch, S. D., La Gerche, A., Roberts, T. J., Prior, D. L., MacIsaac, A. I., & Burns, A. T. (2015) · Pulmonary Circulation · doi:10.1086/681268 · Cited by 53
Survival in pulmonary arterial hypertension patients awaiting lung transplantation
Gomberg-Maitland, M., Glassner-Kolmin, C., Watson, S., Frantz, R., Park, M., Frost, A., Benza, R. L., & Torres, F. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.08.016 · Cited by 47
Impact of high-priority allocation on lung and heart-lung transplantation for pulmonary hypertension
Savale, L., Le Pavec, J., Mercier, O., Mussot, S., Jaïs, X., Fabre, D., O’Connell, C., Montani, D., Stephan, F., Sitbon, O., et al. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.02.034 · Cited by 42
Self-citationA systematic review and meta-analysis of trials using statins in pulmonary arterial hypertension
Anand, V., Garg, S., Duval, S., & Thenappan, T. (2016) · Pulmonary Circulation · doi:10.1086/687304 · Cited by 25
Metadata
- Authors
- Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaïci, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., Dromer, C., Pison, C., Reynaud-Gaubert, M., Haloun, A., Laurent, M., Hachulla, E., Cottin, V., Degano, B., Jaïs, X., Montani, D., Souza, R., & Simonneau, G.
- Venue
- Circulation
- Published
- 2010-07-13
- Volume
- 122
- Issue
- 2
- Pages
- 156-163
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2117339256
- Cited by
- 1,399
- References
- 44
- FWCI
- 91.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.